Literature DB >> 3315796

Haemolysis affects insulin but not C-peptide immunoassay.

S O'Rahilly1, M A Burnett, R F Smith, J H Darley, R C Turner.   

Abstract

Venous blood was taken at the end of a glucose infusion test in 19 individuals and divided into four aliquots, 3 of which were variably haemolysed by repeated passage through a 23-gauge needle to simulate traumatic venepuncture. Plasma insulin (measured by both a charcoal separation and a double-antibody method), C-peptide, and haemoglobin were measured in each aliquot, and haemolysis was also assessed visibly. A significant loss of immuno-assayable plasma insulin was found in samples with only a trace of visible haemolysis, with up to 90% lost in severely haemolysed samples. Plasma C-peptide was unaffected by haemolysis. This represents an additional advantage for the use of plasma C-peptide in assessing insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3315796     DOI: 10.1007/BF00292540

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  4 in total

1.  A modification of the benzidine method for measurement of hemoglobin in plasma and urine.

Authors:  W H CROSBY; F W FURTH
Journal:  Blood       Date:  1956-04       Impact factor: 22.113

2.  A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties.

Authors:  J D Albano; R P Ekins; G Maritz; R C Turner
Journal:  Acta Endocrinol (Copenh)       Date:  1972-07

3.  A structurally abnormal insulin causing human diabetes.

Authors:  H Tager; B Given; D Baldwin; M Mako; J Markese; A Rubenstein; J Olefsky; M Kobayashi; O Kolterman; R Poucher
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

4.  Diabetes: The quest for basal normoglycaemia.

Authors:  R R Holman; R C Turner
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

  4 in total
  22 in total

1.  Disorders of glucose metabolism: post mortem analyses in forensic cases--part II.

Authors:  Frank Musshoff; Cornelius Hess; Burkhard Madea
Journal:  Int J Legal Med       Date:  2010-10-07       Impact factor: 2.686

2.  Limitations of capillary plasma immunoreactive insulin assay as an epidemiological tool.

Authors:  D Simmons; H Dhar; T D Hockaday
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

3.  Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation.

Authors:  Popi Sifianou; Voula Thanou; Helen Karga
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Mar-Apr

4.  Effect of haemolysis on radioimmunoassay for insulin.

Authors:  J A Atchison; W E Grizzle; D J Pillion
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

5.  Observational study of maternal anthropometry and fetal insulin.

Authors:  H Soltani-K; C Bruce; R B Fraser
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-09       Impact factor: 5.747

6.  Hemolysis Affects C-Peptide Immunoassay.

Authors:  Zhi-Qi Wu; Ju Lu; Hua-Guo Xu
Journal:  J Clin Lab Anal       Date:  2016-05-26       Impact factor: 2.352

7.  Individualized correction of insulin measurement in hemolyzed serum samples.

Authors:  Zhi-Qi Wu; Ju Lu; Huanhuan Chen; Wensen Chen; Hua-Guo Xu
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

8.  Degree of methylation of ZAC1 (PLAGL1) is associated with prenatal and post-natal growth in healthy infants of the EDEN mother child cohort.

Authors:  Salah Azzi; Theo C J Sas; Yves Koudou; Yves Le Bouc; Jean-Claude Souberbielle; Patricia Dargent-Molina; Irène Netchine; Marie-Aline Charles
Journal:  Epigenetics       Date:  2013-12-06       Impact factor: 4.528

9.  Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study.

Authors:  Lynn P Lowe; Boyd E Metzger; William L Lowe; Alan R Dyer; Thomas W McDade; H David McIntyre
Journal:  J Clin Endocrinol Metab       Date:  2010-09-15       Impact factor: 5.958

10.  Diagnosis of insulinoma in a patient with hypoglycemia without obvious hyperinsulinemia.

Authors:  Catarina Coelho; Maralyn R Druce; Ashley B Grossman
Journal:  Nat Rev Endocrinol       Date:  2009-11       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.